Drivers of Spatiotemporal Variability in Drinking Water Quality in the United States.

Environ Sci Technol

Bureau of Economic Geology, Jackson School of Geosciences, University of Texas at Austin, Austin, Texas 78758, United States.

Published: September 2022

Approximately 10% of community water systems in the United States experience a health-based violation of drinking water quality; however, recently allocated funds for improving United States water infrastructure ($50 billion) provide an opportunity to address these issues. The objective of this study was to examine environmental, operational, and sociodemographic drivers of spatiotemporal variability in drinking water quality violations using geospatial analysis and data analytics. Random forest modeling was used to evaluate drivers of these violations, including environmental (e.g., landcover, climate, geology), operational (e.g., water source, system size), and sociodemographic (social vulnerability, rurality) drivers. Results of random forest modeling show that drivers of violations vary by violation type. For example, arsenic and radionuclide violations are found mostly in the Southwest and Southcentral United States related to semiarid climate, whereas disinfection byproduct rule violations are found primarily in Southcentral United States related to system operations. Health-based violations are found primarily in small systems in rural and suburban settings. Understanding the drivers of water quality violations can help develop optimal approaches for addressing these issues to increase compliance in community water systems, particularly small systems in rural areas across the United States.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.est.1c08697DOI Listing

Publication Analysis

Top Keywords

united states
24
water quality
16
drinking water
12
drivers spatiotemporal
8
spatiotemporal variability
8
variability drinking
8
water
8
community water
8
water systems
8
quality violations
8

Similar Publications

Since decades after temozolomide was approved, no effective drugs have been developed. Undoubtedly, blood-brain barrier (BBB) penetration is a severe issue that should be overcome in glioblastoma multiforme (GBM) drug development. In this research, we were inspired by linezolid through structural modification with several bioactive moieties to achieve the desired brain delivery.

View Article and Find Full Text PDF

Background: Myotonic dystrophy type 1 (DM1) is a multisystemic, CTG repeat expansion disorder characterized by a slow, progressive decline in skeletal muscle function. A biomarker correlating RNA mis-splicing, the core pathogenic disease mechanism, and muscle performance is crucial for assessing response to disease-modifying interventions. We evaluated the Myotonic Dystrophy Splice Index (SI), a composite RNA splicing biomarker incorporating 22 disease-specific events, as a potential biomarker of DM1 muscle weakness.

View Article and Find Full Text PDF

Background: Kentucky is within the top five leading states for breast mortality nationwide. This study investigates the association between neighborhood socioeconomic disadvantage and breast cancer outcomes, including surgical treatment, radiation therapy, chemotherapy, and survival, and how associations vary by race and ethnicity in Kentucky.

Methods: We conducted a retrospective cohort analysis using data from the Kentucky Cancer Registry (KCR) for breast cancer patients diagnosed between 2010 and 2017, with follow-up through December 31, 2022.

View Article and Find Full Text PDF

Breast cancers of the IntClust-2 type, characterized by amplification of a small portion of chromosome 11, have a median survival of only five years. Several cancer-relevant genes occupy this portion of chromosome 11, and it is thought that overexpression of a combination of driver genes in this region is responsible for the poor outcome of women in this group. In this study we used a gene editing method to knock out, one by one, each of 198 genes that are located within the amplified region of chromosome 11 and determined how much each of these genes contributed to the survival of breast cancer cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!